跳到正文
原文
Endpoints News 生物医药· Max Gelman·· 16 天前AI 评分29

Sanofi 停止开发 Nurix 的 STAT6 蛋白降解药物

Sanofi ends development of Nurix's STAT6 degrader

AI 导读

Sanofi 终止了一款针对 STAT6 蛋白的实验药物开发,该药物被视为下一代免疫学治疗的潜在基石。

正文

Sanofi is drop­ping an ex­per­i­men­tal drug tar­get­ing a path­way that many an­a­lysts see as a po­ten­tial pil­lar of the next gen­er­a­tion of im­munol­o­gy med­i­cine.

The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news